QQQ   268.72 (+1.25%)
AAPL   110.61 (+2.21%)
MSFT   206.42 (+1.59%)
FB   251.11 (+0.63%)
GOOGL   1,426.97 (+0.29%)
AMZN   3,050.59 (+1.02%)
TSLA   402.48 (+3.79%)
NVDA   505.95 (+2.44%)
BABA   267.87 (-0.69%)
CGC   14.05 (-1.54%)
GE   6.07 (+0.17%)
MU   48.66 (-1.64%)
AMD   77.09 (+1.68%)
T   27.86 (-0.64%)
F   6.52 (-2.10%)
ACB   5.03 (-3.27%)
GILD   61.91 (-0.55%)
NFLX   476.39 (+0.70%)
DIS   122.51 (+0.02%)
BAC   23.35 (+0.04%)
BA   152.65 (+4.52%)
QQQ   268.72 (+1.25%)
AAPL   110.61 (+2.21%)
MSFT   206.42 (+1.59%)
FB   251.11 (+0.63%)
GOOGL   1,426.97 (+0.29%)
AMZN   3,050.59 (+1.02%)
TSLA   402.48 (+3.79%)
NVDA   505.95 (+2.44%)
BABA   267.87 (-0.69%)
CGC   14.05 (-1.54%)
GE   6.07 (+0.17%)
MU   48.66 (-1.64%)
AMD   77.09 (+1.68%)
T   27.86 (-0.64%)
F   6.52 (-2.10%)
ACB   5.03 (-3.27%)
GILD   61.91 (-0.55%)
NFLX   476.39 (+0.70%)
DIS   122.51 (+0.02%)
BAC   23.35 (+0.04%)
BA   152.65 (+4.52%)
QQQ   268.72 (+1.25%)
AAPL   110.61 (+2.21%)
MSFT   206.42 (+1.59%)
FB   251.11 (+0.63%)
GOOGL   1,426.97 (+0.29%)
AMZN   3,050.59 (+1.02%)
TSLA   402.48 (+3.79%)
NVDA   505.95 (+2.44%)
BABA   267.87 (-0.69%)
CGC   14.05 (-1.54%)
GE   6.07 (+0.17%)
MU   48.66 (-1.64%)
AMD   77.09 (+1.68%)
T   27.86 (-0.64%)
F   6.52 (-2.10%)
ACB   5.03 (-3.27%)
GILD   61.91 (-0.55%)
NFLX   476.39 (+0.70%)
DIS   122.51 (+0.02%)
BAC   23.35 (+0.04%)
BA   152.65 (+4.52%)
QQQ   268.72 (+1.25%)
AAPL   110.61 (+2.21%)
MSFT   206.42 (+1.59%)
FB   251.11 (+0.63%)
GOOGL   1,426.97 (+0.29%)
AMZN   3,050.59 (+1.02%)
TSLA   402.48 (+3.79%)
NVDA   505.95 (+2.44%)
BABA   267.87 (-0.69%)
CGC   14.05 (-1.54%)
GE   6.07 (+0.17%)
MU   48.66 (-1.64%)
AMD   77.09 (+1.68%)
T   27.86 (-0.64%)
F   6.52 (-2.10%)
ACB   5.03 (-3.27%)
GILD   61.91 (-0.55%)
NFLX   476.39 (+0.70%)
DIS   122.51 (+0.02%)
BAC   23.35 (+0.04%)
BA   152.65 (+4.52%)
Log in
NASDAQ:AUVI

Applied UV Stock Forecast, Price & News

$7.70
+0.09 (+1.18 %)
(As of 09/25/2020 11:17 AM ET)
Add
Compare
Today's Range
$7.58
Now: $7.70
$7.75
50-Day Range N/A
52-Week Range
$5.14
Now: $7.70
$12.99
Volume475 shs
Average Volume728,434 shs
Market Capitalization$49.23 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Applied UV, Inc. engages in the development and acquisition of technology that address infection prevention in the healthcare, hospitality, commercial, and residential markets. Its products utilize disinfection technology that applies the power of narrow-range light (UVC) to destroy pathogens thoroughly and automatically. The company was founded in 2012 and is based in Mount Vernon, New York.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.00 out of 5 stars


Industry, Sector and Symbol

Industry Electric lighting & wiring equipment
Sub-IndustryN/A
Current SymbolNASDAQ:AUVI
CUSIPN/A
CIKN/A
Phone929-207-3751

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees26
Market Cap$49.23 million
Next Earnings DateN/A
OptionableNot Optionable
$7.70
+0.09 (+1.18 %)
(As of 09/25/2020 11:17 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive AUVI News and Ratings via Email

Sign-up to receive the latest news and ratings for AUVI and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Applied UV (NASDAQ:AUVI) Frequently Asked Questions

Who are some of Applied UV's key competitors?

What other stocks do shareholders of Applied UV own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Applied UV investors own include DiamondPeak (DPHC), Draftkings (DKNG), Gevo (GEVO), Inovio Pharmaceuticals (INO), Kosmos Energy (KOS), Ladder Capital (LADR), AG Mortgage Investment Trust (MITT), Nano-X Imaging (NNOX), Transocean (RIG) and Spirit Airlines (SAVE).

Who are Applied UV's key executives?

Applied UV's management team includes the following people:
  • Mr. Keyoumars Saeed, CEO & Director (Age 56)
  • Max Munn, Pres & Director
  • Mr. Joseph N. Himy, Chief Financial Officer (Age 50)
  • Mr. James L. Doyle III, Chief Operations Officer

When did Applied UV IPO?

(AUVI) raised $5 million in an initial public offering on the week of August 31st 2020. The company issued 1,000,000 shares at a price of $5.00 per share. Network 1 Financial Securities, Inc. served as the underwriter for the IPO and Dawson James Securities was co-manager.

What is Applied UV's stock symbol?

Applied UV trades on the NASDAQ under the ticker symbol "AUVI."

When does the company's quiet period expire?

Applied UV's quiet period expires on Monday, October 12th. Applied UV had issued 1,000,000 shares in its IPO on August 31st. The total size of the offering was $5,000,000 based on an initial share price of $5.00. During the company's quiet period, underwriters and any insiders involved in the IPO are restricted from issuing any research reports or earnings estimates for the company because of SEC regulations. Following the end of the company's quiet period, it's expected that the brokerages that served as underwriters on the stock will initiate research coverage on the company.

How do I buy shares of Applied UV?

Shares of AUVI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Applied UV's stock price today?

One share of AUVI stock can currently be purchased for approximately $7.70.

How big of a company is Applied UV?

Applied UV has a market capitalization of $49.23 million. Applied UV employs 26 workers across the globe.

What is Applied UV's official website?

The official website for Applied UV is www.applieduvinc.com.

How can I contact Applied UV?

Applied UV's mailing address is 150 N. MACQUESTEN PKWY, MOUNT VERNON NY, 10550. The company can be reached via phone at 929-207-3751 or via email at [email protected]

This page was last updated on 9/25/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.